Peter Jeffrey Conn
Director/Board Member at Appello Pharmaceuticals, Inc.
Peter Jeffrey Conn active positions
| Companies | Position | Start | End |
|---|---|---|---|
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Director/Board Member | - | - |
Career history of Peter Jeffrey Conn
Former positions of Peter Jeffrey Conn
| Companies | Position | Start | End |
|---|---|---|---|
| KARA THER | Founder | 30/06/2009 | - |
Statistics
International
| United States | 3 |
Operational
| Founder | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |
- Stock Market
- Insiders
- Peter Jeffrey Conn
- Experience
